Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical
evidence of tissue hypoperfusion and can lead to multi‐organ failure and death depending …

Despite an improvement in pharmacological therapies and mechanical reperfusion, the
outcome of patients with acute myocardial infarction (AMI) is still suboptimal, especially in …

In recent years, more attention has been paid to expanding the abundance of Circular RNAs
(circRNAs), while the circRNAs that have been found to have significant functions have not …

Background: Vasopressors are frequently utilized for blood pressure stabilization in patients
with cardiogenic shock (CS), although with a questionable benefit. Obtaining central venous …

Background and Objectives: Sex-specific outcome in patients with acute myocardial
infarction-related cardiogenic shock (AMI-CS) receiving temporary mechanical circulatory …

Background Cardiogenic shock (CS) complicates 5%-10% of acute myocardial infarction
(AMI) and is the leading cause of early mortality. It remains unclear whether percutaneous …

Cardiogenic shock (CS) is a time-sensitive and hemodynamically complex syndrome with a
broad spectrum of etiologies and clinical presentations. Despite contemporary therapies, CS …

Acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is a life-
threatening condition frequently encountered in patients with multivessel coronary artery …

Introduction: Acute myocardial infarction (AMI) is characterized by the loss of
cardiomyocytes, which impairs cardiac function and eventually leads to heart failure. The …

Among patients with acute myocardial infarction (MI) complicated by cardiogenic shock
(CS), in-hospital mortality remains high. In the present study, we aimed to identify factors …